dalteparin has been researched along with Diffuse Large B-Cell Lymphoma in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fricker, J | 1 |
| Fasano, R | 1 |
| Kent, P | 1 |
| Valentino, L | 1 |
1 review available for dalteparin and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Superior vena cava thrombus treated with low-dose, peripherally administered recombinant tissue plasminogen activator in a child: case report and review of the literature.
Topics: Anti-Bacterial Agents; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; C | 2005 |
1 other study available for dalteparin and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
50th ASH Annual Meeting.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Humans; Lenalidomide; Leukemia, Lymp | 2009 |